SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - EX-101.INS
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - EX-101.INS

Footer disclaimer

Footer disclaimer

© Natera 2019. All Rights Reserved. The tests described on this site were developed by Natera, Inc. a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). The tests have not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests.